SCHEMBL30984048

SCHEMBL30984048

CC1(Oc2ncnc3c2nc(-c2ccc(OCCN4CCNCC4)cc2Cl)n3Cc2cc(Cl)ccn2)CC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.38
▸ DRD2 P14416 7/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HRH4 Q9H3N8 4/20 0.35
▸ CNR1 P21554 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ ALK Q9UM73 1/20 0.33
▸ PRKAB2 O43741 1/20 0.33
▸ PRKAG1 P54619 1/20 0.33
▸ PRKAA2 P54646 1/20 0.33
▸ PRKAA1 Q13131 1/20 0.33
▸ PRKAG3 Q9UGI9 1/20 0.33
▸ PRKAG2 Q9UGJ0 1/20 0.33
▸ PRKAB1 Q9Y478 1/20 0.33
▸ EGFR P00533 1/20 0.32
▸ ERBB2 P04626 1/20 0.32
▸ HTR6 P50406 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983467 0.94 PDE2A (0.38) PDE2ADRD2KDM4EALDH1A1HRH4
SCHEMBL31268876 0.94 PDE2A (0.37) PDE2ADRD2KDM4EALDH1A1HRH4
SCHEMBL31268937 0.94 PDE2A (0.36) PDE2ADRD2KDM4EALDH1A1CNR1
SCHEMBL30983569 0.93 PDE2A (0.37) PDE2ADRD2KDM4EALDH1A1HRH4
SCHEMBL30983551 0.93 PDE2A (0.37) PDE2ADRD2KDM4EALDH1A1HRH4
SCHEMBL31268825 0.93 PDE2A (0.36) PDE2ADRD2KDM4EALDH1A1HRH4
SCHEMBL31269142 0.92 PDE2A (0.38) PDE2ADRD2KDM4EALDH1A1HRH4
SCHEMBL30983930 0.92 PDE2A (0.39) PDE2ADRD2KDM4EALDH1A1HRH4
SCHEMBL30983576 0.92 DRD2 (0.41) PDE2ADRD2HRH4SIGMAR1ALK
SCHEMBL30983522 0.91 PDE2A (0.41) PDE2ADRD2KDM4EALDH1A1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback